876148-48-0

Basic information

• Product Name: Benzoic acid, 3-[3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-piperidinyl]-, methyl ester
• CAS NO: 876148-48-0
• Molecular Formula: C20H33NO3Si
• Molecular Weight: 363.572
• Mol File: 876148-48-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-[3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-piperidinyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-[3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-piperidinyl]-, methyl ester(876148-48-0)
• EPA Substance Registry System: Benzoic acid, 3-[3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1-piperidinyl]-, methyl ester(876148-48-0)

Safety Data

• Hazardous Substances Data: 876148-48-0(Hazardous Substances Data)

Upstream product

• 876147-50-1 3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]piperidine 
• 99769-19-4 [3-(methoxycarbonyl)phenyl]boronic acid 

Downstream Products

• 876147-88-5 methyl 3-[3-(hydroxymethyl)piperidin-1-yl]benzoate 

Relevant articles and documents

NOVEL CYCLIC AMINOBENZOIC ACID DERIVATIVE

The present invention relates to cyclic amino benzoic acid derivatives which are effective in therapy of lipid metabolism abnormality, diabetes and the like as a human peroxisome proliferators-activated receptor (PPAR) agonist, in particular, as an agonist against human PPARα isoform, and addition salts thereof, and pharmaceutical compositions containing these compounds. A cyclic amino benzoic acid derivative represented by the general formula (1) [wherein a ring Ar represents an aryl group which may have substituent, or the like; Y represents a C1-C4 alkylene, C2-C4 alkenylene, C2-C4 alkynylene, or the like; Z represents an oxygen atom, sulfur atom or - (CH2)n- (n represents 0,1 or 2) ; X represents a hydrogen atom, halogen atom, lower alkyl group which may be substituted with a halogen atom, or the like; R represents a hydrogen atom or lower alkyl group, and -COOR substitutes for an ortho position or metha position of binding position of ring W] or a pharmaceutically acceptable salt thereof.